About FAST
Scientific Advisory Board
These individuals review and give constructive feedback on the translational relevance, scientific rigor, track record and expertise of the investigator, proposed timeline and associated budget of the project, and overall feasibility and probabilities of the suggested research. (In addition, there are scientific consultants that volunteer to review for FAST, who we will leverage if the topic is in an area outside of the scope of members of the SAB, or there is any conflict of interest for members of the SAB.) This process is led by the chair of the Scientific Advisory Board, Dr. Barbara Bailus.
At the same time, legal teams negotiate a contract to govern the grant and any advancements that may come from the grant. If and when all is ripe and the grant is approved by the chair of the SAB, the Chief Science Officer, and the entire FAST Board of Directors, then the contract is signed and the work can begin immediately.
Barbara Bailus, Ph.D.
Scientific Advisory Board Chair
Keck Graduate Institute, Claremont Colleges
Assistant Professor of Genetics
Specialty: Genetic Engineering, Protein Delivery
Anne Anderson, MD
Associate Professor
Departments of Pediatrics and Neurology and Division of Neuroscience Baylor College of Medicine Houston, TX
Specialties: Clinical Neurophysiology, Pediatric Neurology
Joseph Anderson, Ph.D.
Associate Professor
Associate Professor with the Gene Therapy Center at UC Davis.
Specialty: Infectious Diseases, Internal Medicine
Nadia Bahi-Buisson, PhD.
Board Member
University professor and hospital practitioner in the Neuropediatrics Department of CHU Necker Enfants - Malades
Université Paris Descarte
Mei Baker, MD, FACMG
Board Member
University of Wisconsin School of Medicine and Public Health
Specialty: Newborn Screening (NBS)
Art Beaudet, MD
Founder and CEO of Luna Genetics
Elizabeth Berry-Kravis, Ph.D.
Professor
Lauren E. Black, Ph.D.
Distinguished Scientist
Charles River Laboratories Specialty: preclinical assessment of transplant drugs, oligos, monoclonals for autoimmune disease, treatment vaccines, and cell therapies
Robert Carson, Ph.D.
Professor
Vanderbilt Children’s Hospital, Nashville, TN
Specialty: Epilepsy, Pediatric Neurology
Kyle Fink, Ph.D.
Assistant Adjunct Professor
University of California, Davis Department of Neurology
Specialty: Translational research for genetically linked neurological disorders
Albert Keung, Ph.D.
Assistant Professor of Chemical and Biomolecular Engineering
NC State University
Speciality: stem cell models and molecular tools to understand epigenetic mechanisms of the human brain
Eric Klann, Ph.D.
Professor
New York University
Professor and Director Center for Neural Science
Specialties: Learning & Memory; Cognitive Disorders
Cesar Ochoa-Lubinoff, Ph.D.
Board Member
Specialty: Pediatric Psychology, Pediatric Psychiatry, Developmental Behavior
University of California, Los Angeles
Bryce Reeve, Ph.D.
Professor in Population Health Sciences
David Segal, Ph.D.
Professor
UC Davis School of Medicine
UC Davis Genome Center, Department of Biochemistry and Molecular Medicine, Pharmacology, MIND Institute, Specialty: Genomic therapeutics
Keith Sutton, Ph.D.
Board Member
Ashley Winslow, Ph.D.
Distinguished Scientist
Chief Science Officer, Odylia Therapeutics
Specialty: Gene Therapy and Clinical Development